MediPharm Labs Corp. (TSX: LABS)

Market Cap	28.78M
Revenue (ttm)	39.05M
Net Income (ttm)	-11.76M
Shares Out	411.12M
EPS (ttm)	-0.03
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	123,505
Open	0.0700
Previous Close	0.0700
Day's Range	0.0650 - 0.0700
52-Week Range	0.0600 - 0.1000
Beta	0.88
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 14, 2024

About MediPharm Labs

MediPharm Labs Corp., a pharmaceutical company, engages in the production and sale of purified, pharmaceutical-quality cannabis extracts, concentrates, active pharmaceutical ingredients, and advanced derivative products in Canada, Australia, Germany, and internationally. The company formulates, processes, packages, and distributes cannabis active ingredients and advanced cannabinoid-based products. It also provides good manufacturing practice flower sourcing, packaging, and distribution services, as well as dried flower and pre-roll cannabis pr...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2015
• Employees: 166
• Stock Exchange: Toronto Stock Exchange
• Ticker Symbol: LABS

Financial Performance

In 2023, MediPharm Labs's revenue was 33.06 million, an increase of 49.49% compared to the previous year's 22.12 million. Losses were -13.08 million, -56.37% less than in 2022.